340B Lines Hospital’s Pockets

A new report on the 340B program shows how hospitals and clinics profit off the program while leaving vulnerable patients behind. The report, done by consulting firm BRG, found that hospitals participating in the program pocketed $142.2 billion dollars in profits from the drug discount program in 2025 alone. The 340B program was initially designed to increase access to vital medicines for low-income patients seeking care at nonprofit hospitals; however, abuse of this program has increased the cost of employer-sponsored insurance and healthcare costs overall. Our Health Equity advocates for meaningful reforms to the 340B program that place patients over profits. Read more here.